Neurizon Therapeutics Limited

ASX:NUZ Stock Report

Market Cap: AU$94.9m

Neurizon Therapeutics Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Neurizon Therapeutics.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth54.6%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Here's Why We're Not Too Worried About PharmAust's (ASX:PAA) Cash Burn Situation

Apr 09
Here's Why We're Not Too Worried About PharmAust's (ASX:PAA) Cash Burn Situation

Here's Why We're Not At All Concerned With PharmAust's (ASX:PAA) Cash Burn Situation

Mar 31
Here's Why We're Not At All Concerned With PharmAust's (ASX:PAA) Cash Burn Situation

Here's Why PharmAust Limited's (ASX:PAA) CEO Compensation Is The Least Of Shareholders Concerns

Nov 03
Here's Why PharmAust Limited's (ASX:PAA) CEO Compensation Is The Least Of Shareholders Concerns

Is PharmAust (ASX:PAA) In A Good Position To Deliver On Growth Plans?

May 30
Is PharmAust (ASX:PAA) In A Good Position To Deliver On Growth Plans?

This Is The Reason Why We Think PharmAust Limited's (ASX:PAA) CEO Might Be Underpaid

Oct 14
This Is The Reason Why We Think PharmAust Limited's (ASX:PAA) CEO Might Be Underpaid

What Does PharmAust's (ASX:PAA) CEO Pay Reveal?

Feb 14
What Does PharmAust's (ASX:PAA) CEO Pay Reveal?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Neurizon Therapeutics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

ASX:NUZ - Analysts future estimates and past financials data (AUD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20241-9-5-5N/A
3/31/20241-6-3-3N/A
12/31/20234-8-2-2N/A
9/30/20234-7-2-2N/A
6/30/20231-2-2-2N/A
3/31/20232-1-1-1N/A
12/31/20224-100N/A
9/30/20224-1-1-1N/A
6/30/20225-2-1-1N/A
3/31/20224-2-1-1N/A
12/31/20214-2-2-1N/A
9/30/20214-2-1-1N/A
6/30/20214-1-1-1N/A
3/31/20214-2-1-1N/A
12/31/20203-200N/A
9/30/20204-2-1-1N/A
6/30/20204-1-1-1N/A
3/31/20204-2-2-2N/A
12/31/20194-2-2-2N/A
9/30/20194-2-2-2N/A
6/30/20194-2-2-2N/A
3/31/20194-1-2-1N/A
12/31/20184-1-2-1N/A
9/30/20184-2-2-1N/A
6/30/20183-3-2-2N/A
3/31/20183-2N/A-2N/A
12/31/20173-2N/A-2N/A
9/30/20173-2N/A-1N/A
6/30/20173-1N/A-1N/A
3/31/20173-2N/A-1N/A
12/31/20163-3N/A-1N/A
9/30/20163-4N/A-1N/A
6/30/20163-4N/A-2N/A
3/31/20163-3N/A-2N/A
12/31/20153-2N/A-2N/A
9/30/20153-2N/A-2N/A
6/30/20152-2N/A-2N/A
3/31/20152-2N/A-2N/A
12/31/20142-2N/A-1N/A
9/30/20142-2N/A-1N/A
6/30/20142-1N/A-2N/A
12/31/20132-1N/A-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if NUZ's forecast earnings growth is above the savings rate (2.4%).

Earnings vs Market: Insufficient data to determine if NUZ's earnings are forecast to grow faster than the Australian market

High Growth Earnings: Insufficient data to determine if NUZ's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if NUZ's revenue is forecast to grow faster than the Australian market.

High Growth Revenue: Insufficient data to determine if NUZ's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if NUZ's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y